- [Getting GHK-Cu](/)
- Prescription

# What happens in a GHK-Cu prescription review?

Reading about a treatment can help you ask questions. The decision still needs a person looking at your health.

![A copper downpipe bends below a roof edge on a pale apartment exterior.](/getting-roof-3a92a591b470/route-downpipe.webp)

![A copper downpipe bends below a roof edge on a pale apartment exterior.](/getting-roof-3a92a591b470/route-downpipe.webp)

1

## First, which route are we talking about?

GHK-Cu skin preparations and injections need separate conversations. A cream starts at the skin; an injection puts material inside the body. Evidence about one can’t establish the other’s benefits or safety.

Even the [review of topical research](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/) describes gaps in skin delivery and human studies. A promising ingredient still needs testing in the preparation and setting being proposed.

I look for the purpose as well as the route. “Peptide therapy” alone doesn’t tell me either. The useful question is what has been measured in people for that particular use, and what the evidence leaves unanswered.

2

## A withdrawn request doesn’t mean clearance

On the [FDA page current as of April 22, 2026](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks), GHK-Cu for injectable routes appears under “nominated but withdrawn.” It was previously in Category 2. The request was withdrawn by its nominator; FDA gives no withdrawal date for this substance.

Withdrawal isn’t clearance, FDA approval or permission to compound. The page still prints concerns about possible immune reactions related to peptide clumping and impurities, alongside limited human safety data.

That entry is specifically about injections. It doesn’t describe all GHK-Cu skin products. I find those few words about the route easy to lose when a headline shortens the FDA wording.

![Rain beads gather along a green-patinated copper lip beside pale plaster.](/getting-roof-3a92a591b470/rain-close.webp)

3

## A service listing is only a starting point

Promise Peptides offers prescription review for compounded GHK-Cu injections at mypromise.com. A licensed U.S. provider assesses each request and may decline to prescribe. Care is for U.S. patients only; availability varies with the state and treatment.

Compounded means the medicine is prepared for a patient rather than supplied as an approved finished drug. This compounded medicine is not FDA-approved. A prescription doesn’t change that status.

The listing tells you the service discusses this treatment. It can’t tell you whether it fits your health or what result to expect. Those answers aren’t decided by reaching a product page.

4

## Leave room for a no

The [often-cited metabolism study](https://pubmed.ncbi.nlm.nih.gov/9187381/) used plain GHK in rats. The evidence covered here gives no validated human half-life for injected GHK-Cu. That’s one of the gaps a careful discussion has to acknowledge.

Questions about copper-handling conditions, other medicines and your health history belong with the clinician doing the assessment. So do questions about the expected benefit, unknown risks and follow-up.

These are conversation topics, not an official screening checklist. A clinician can decide against treatment. Understanding the reading can make that conversation clearer, but it can’t make an uncertain treatment a settled answer or replace an assessment.

[Visit the reading shelf](/references)[Back to the beginning](/)

---

[Skip to the story](/prescription#main-story)

 [Getting GHK-Cu](/)

[Research](/research) [Routes](/prescription) [About](/about)

[Start here](/) [Research](/research) [Skin](/skin-research) [Effects](/effects) [Study amounts](/dosage) [Prescription review](/prescription) [Questions](/faq) [Sources](/references) [About](/about) [Contact](/contact)

Getting GHK-Cu is a place to read and ask better questions; there is no clinic, pharmacy or sales counter here.

© 2026 Getting GHK-Cu